DE69214130D1 - Verfahren zum hervorheben von prägungen in tabletten - Google Patents

Verfahren zum hervorheben von prägungen in tabletten

Info

Publication number
DE69214130D1
DE69214130D1 DE69214130T DE69214130T DE69214130D1 DE 69214130 D1 DE69214130 D1 DE 69214130D1 DE 69214130 T DE69214130 T DE 69214130T DE 69214130 T DE69214130 T DE 69214130T DE 69214130 D1 DE69214130 D1 DE 69214130D1
Authority
DE
Germany
Prior art keywords
tablets
highlights
solvent
filling material
waxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69214130T
Other languages
English (en)
Other versions
DE69214130T2 (de
Inventor
Paul Gilis
Conde Valentin De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Application granted granted Critical
Publication of DE69214130D1 publication Critical patent/DE69214130D1/de
Publication of DE69214130T2 publication Critical patent/DE69214130T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
DE69214130T 1991-02-27 1992-02-14 Verfahren zum hervorheben von prägungen in tabletten Expired - Lifetime DE69214130T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP91200417 1991-02-27
PCT/EP1992/000358 WO1992015288A1 (en) 1991-02-27 1992-02-14 A method of highlighting intagliations in tablets

Publications (2)

Publication Number Publication Date
DE69214130D1 true DE69214130D1 (de) 1996-10-31
DE69214130T2 DE69214130T2 (de) 1997-02-06

Family

ID=8207528

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69214130T Expired - Lifetime DE69214130T2 (de) 1991-02-27 1992-02-14 Verfahren zum hervorheben von prägungen in tabletten

Country Status (16)

Country Link
US (1) US5405642A (de)
EP (2) EP0573462B1 (de)
JP (1) JP3237758B2 (de)
AT (1) ATE143259T1 (de)
AU (1) AU1260392A (de)
CA (1) CA2104096C (de)
DE (1) DE69214130T2 (de)
DK (1) DK0573462T3 (de)
ES (1) ES2094902T3 (de)
GR (1) GR3021929T3 (de)
IE (1) IE75729B1 (de)
MX (1) MX9200831A (de)
NZ (1) NZ241613A (de)
TW (1) TW201697B (de)
WO (1) WO1992015288A1 (de)
ZA (1) ZA921428B (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6113945A (en) * 1996-02-26 2000-09-05 L. Perrigo Company Multi-colored medicament
US5827535A (en) * 1996-06-21 1998-10-27 Banner Pharmacaps, Inc. Graphically impressed softgel and method for making same
DK0927556T3 (da) * 1997-09-23 2000-11-20 Akzo Nobel Nv Coatede dosisenheder
US6685961B1 (en) 2000-10-24 2004-02-03 Banner Pharmacaps, Inc. Colored gelatin-based formulations and method
GB0110846D0 (en) * 2001-05-02 2001-06-27 Phoqus Ltd Tablets with coloured patterns
US7183410B2 (en) * 2001-08-02 2007-02-27 Bidachem S.P.A. Stable polymorph of flibanserin
US20030060475A1 (en) * 2001-08-10 2003-03-27 Boehringer Ingelheim Pharma Kg Method of using flibanserin for neuroprotection
US7122143B2 (en) * 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
JP2005509605A (ja) 2001-09-28 2005-04-14 マクニール−ピーピーシー・インコーポレイテッド 可食性組成物と可食性外皮を含む剤形
US7323192B2 (en) * 2001-09-28 2008-01-29 Mcneil-Ppc, Inc. Immediate release tablet
US6837696B2 (en) * 2001-09-28 2005-01-04 Mcneil-Ppc, Inc. Apparatus for manufacturing dosage forms
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
UA78974C2 (en) 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
US20040048877A1 (en) * 2002-05-22 2004-03-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions containing flibanserin
WO2004003089A1 (en) * 2002-06-26 2004-01-08 Mars, Incorporated Edible inks for ink-jet printing on edible substrates
US7029112B2 (en) * 2002-08-05 2006-04-18 Mars, Incorporated Ink-jet printing on surface modified edibles and products made
US7807197B2 (en) * 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
US7906167B2 (en) 2003-03-07 2011-03-15 Mars Incorporated Water based inks for printing on confectionery
US20050074514A1 (en) * 2003-10-02 2005-04-07 Anderson Oliver B. Zero cycle molding systems, methods and apparatuses for manufacturing dosage forms
US20050239798A1 (en) * 2004-04-22 2005-10-27 Boehringer Ingelheim Pharmaceuticals, Inc. Method for the treatment of premenstrual and other female sexual disorders
MXPA06012059A (es) * 2004-04-22 2007-01-25 Boehringer Ingelheim Int Nuevas composiciones farmaceuticas para el tratamiento de los trastornos sexuales ii.
US20060025420A1 (en) * 2004-07-30 2006-02-02 Boehringer Ingelheimn International GmbH Pharmaceutical compositions for the treatment of female sexual disorders
EP1789048A1 (de) * 2004-09-03 2007-05-30 Boehringer Ingelheim International GmbH Verfahren zur behandlung von aufmerksamkeitsdefizitstörung mit hyperaktivität
US8383159B2 (en) * 2004-10-27 2013-02-26 Mcneil-Ppc, Inc. Dosage forms having a microreliefed surface and methods and apparatus for their production
US20070190133A1 (en) * 2004-10-27 2007-08-16 Bunick Frank J Dosage forms having a microreliefed surface and methods and apparatus for their production
US20060088587A1 (en) * 2004-10-27 2006-04-27 Bunick Frank J Dosage forms having a microreliefed surface and methods and apparatus for their production
US20060087051A1 (en) * 2004-10-27 2006-04-27 Bunick Frank J Dosage forms having a microreliefed surface and methods and apparatus for their production
US20060088586A1 (en) * 2004-10-27 2006-04-27 Bunick Frank J Dosage forms having a microreliefed surface and methods and apparatus for their production
US20060088593A1 (en) * 2004-10-27 2006-04-27 Bunick Frank J Dosage forms having a microreliefed surface and methods and apparatus for their production
US20070281022A1 (en) * 2004-10-27 2007-12-06 Bunick Frank J Dosage forms having a microreliefed surface and methods and apparatus for their production
WO2006096439A2 (en) * 2005-03-04 2006-09-14 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases
JP2008538741A (ja) * 2005-03-04 2008-11-06 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 鬱病の治療用及び／又は予防用の医薬組成物
WO2006096434A2 (en) * 2005-03-04 2006-09-14 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
US8673352B2 (en) * 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
CA2608249A1 (en) * 2005-05-06 2006-11-16 Boehringer Ingelheim International Gmbh Method for the treatment of drug abuse with flibanserin
US20060264511A1 (en) * 2005-05-19 2006-11-23 Boehringer Ingelheim International Gmbh Method for the treatment of drug-induced sexual dysfunction
CA2608713A1 (en) * 2005-05-19 2006-11-23 Boehringer Ingelheim International Gmbh Method for the treatment of sexual dysfunctions due to medical conditions
US8227476B2 (en) 2005-08-03 2012-07-24 Sprout Pharmaceuticals, Inc. Use of flibanserin in the treatment of obesity
WO2007035926A2 (en) * 2005-09-22 2007-03-29 Bpsi Holdings, Inc. Method for printing on tablets and etched printing plate used therein
EP1945214A1 (de) * 2005-10-29 2008-07-23 Boehringer Ingelheim International GmbH Benzimidazolon-derivate zur behandlung von prämenstruellen und anderen sexuellen störungen der frau
US20070123540A1 (en) * 2005-10-29 2007-05-31 Angelo Ceci Sexual desire enhancing medicaments comprising benzimidazolone derivatives
US20070105869A1 (en) * 2005-11-08 2007-05-10 Stephane Pollentier Use of flibanserin for the treatment of pre-menopausal sexual desire disorders
CA2649938A1 (en) * 2006-05-09 2007-11-15 Boehringer Ingelheim International Gmbh Use of flibanserin for the treatment of post-menopausal sexual desire disorders
ATE456369T1 (de) 2006-06-30 2010-02-15 Boehringer Ingelheim Int Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen
CA2657043A1 (en) * 2006-07-14 2008-01-17 Boehringer Ingelheim International Gmbh Use of flibanserin for the treatment of sexual disorders in females
WO2008019996A2 (en) * 2006-08-14 2008-02-21 Boehringer Ingelheim International Gmbh Formulations of flibanserin and method for manufacturing the same
CL2007002214A1 (es) * 2006-08-14 2008-03-07 Boehringer Ingelheim Int Composicion farmaceutica en la forma de comprimido, donde al menos la longitud del comprimido en el estado anterior de la aplicacion es al menos 7/12 del diametro pilorico del paciente y despues de ingerirlo en estado alimentado, la longitud del comp
MX2009002031A (es) * 2006-08-25 2009-03-06 Boehringer Ingelheim Int Sistema de liberacion controlada y metodo para fabricarlo.
CL2008002693A1 (es) 2007-09-12 2009-10-16 Boehringer Ingelheim Int Uso de flibanserina para el tratamiento de sintomas vasomotores seleccionados de sofocos, sudores nocturnos, cambios de estado de animo e irritabilidad

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3125490A (en) * 1964-03-17 Tablet with contrasting indicia and method
US3436453A (en) * 1963-06-14 1969-04-01 American Cyanamid Co Surface dyed edible gelatin capsule with pigment marking
FR1426194A (fr) * 1964-10-20 1966-01-28 Ile De France Nouvelle technique d'enrobage des comprimés
US3539380A (en) * 1968-01-08 1970-11-10 Upjohn Co Methylcellulose and polyalkylene glycol coating of solid medicinal dosage forms
IE53157B1 (en) * 1981-03-09 1988-08-03 Ici Plc Coated coloured intagliated articles
JPS58152813A (ja) * 1982-03-08 1983-09-10 Sumitomo Chem Co Ltd 鮮明な刻印を有する錠剤およびその製法
JPS58192819A (ja) * 1982-05-04 1983-11-10 Sumitomo Chem Co Ltd 鮮明な刻印を有する錠剤の製法
KR840000624A (ko) * 1982-06-02 1984-02-25 원본미기재 부식억제 페인트 조성물
ATE29664T1 (de) * 1982-06-10 1987-10-15 Ici Plc Herstellung von deutlich vertieft gepraegten gegenstaenden.
US4576646A (en) * 1983-07-06 1986-03-18 Seppic Film-forming compositions for enveloping solid forms, particularly pharmaceutical or food products or seeds, and products obtained, coated with said compositions
FR2548675B1 (fr) * 1983-07-06 1987-01-09 Seppic Sa Compositions filmogenes pour enrobage des formes solides de produits pharmaceutiques ou alimentaires et produits obtenus revetus desdites compositions
US5006362A (en) * 1988-05-09 1991-04-09 Berwind Pharmaceutical Services, Inc. Branding pharmaceutical dosage forms, food and confectionery products with aqueous ingestible inks
US5098715A (en) * 1990-12-20 1992-03-24 Burroughs Wellcome Co. Flavored film-coated tablet

Also Published As

Publication number Publication date
DE69214130T2 (de) 1997-02-06
ES2094902T3 (es) 1997-02-01
MX9200831A (es) 1992-08-01
AU1260392A (en) 1992-10-06
DK0573462T3 (da) 1996-11-11
US5405642A (en) 1995-04-11
EP0501553A1 (de) 1992-09-02
ATE143259T1 (de) 1996-10-15
GR3021929T3 (en) 1997-03-31
JPH06504935A (ja) 1994-06-09
IE920611A1 (en) 1992-09-09
CA2104096A1 (en) 1992-08-28
EP0573462B1 (de) 1996-09-25
ZA921428B (en) 1993-08-26
CA2104096C (en) 2003-06-10
TW201697B (de) 1993-03-11
JP3237758B2 (ja) 2001-12-10
NZ241613A (en) 1993-06-25
WO1992015288A1 (en) 1992-09-17
EP0573462A1 (de) 1993-12-15
IE75729B1 (en) 1997-09-24

Similar Documents

Publication Publication Date Title
DE69214130T2 (de) Verfahren zum hervorheben von prägungen in tabletten
DE59003545D1 (de) Verfahren zum Färben von Polyamidsubstraten.
DE69005926D1 (de) Verfahren zum Beschichten von Titandioxidpigmenten.
DE68921194T2 (de) Verfahren zum Beschichten von Superlegierungen mit yttriumangereicherten Aluminiden.
DE59201211D1 (de) Verfahren zum Einfärben von Baustoffen.
DE69424559D1 (de) Verfahren zum regeln der farbdichte
DE69634708D1 (de) Verfahren zum Etikettieren von Behältern
DE69201913T2 (de) Verfahren zum Trocknen von Gegenständen.
DE69206409D1 (de) Verbessertes verfahren zum überziehen von alkylketendimeren auf titaniumdioxid.
DE69301060D1 (de) Verfahren zum Aufbringen von Lot
DE59203797D1 (de) Verfahren zum Einfärben von Baustoffen.
DE69604962D1 (de) Verfahren zum Anbringen von Hydrogel-Überzügen auf embryonale Pflanzen
DE69331887D1 (de) Verfahren zum Lernen von Mustern
DE69105592T2 (de) Verfahren zum Färben von photochromen Gläsern.
DE58906043D1 (de) Verfahren zum färben von haaren mit pflanzenfarben.
DE69205482D1 (de) Verfahren zum Verpacken von Gegenständen.
DE69110232D1 (de) Verfahren zum färben von polymeren.
ATA91891A (de) Verfahren zum bleichen von cellulosehaeltigem material
DE69113986D1 (de) Verfahren zum steuern von farben auf einem bildschirm.
DE59003396D1 (de) Verfahren zum Färben von Papier.
DE69309363T2 (de) Verfahren zum Indigofärben von Strähngarnen
DE59007973D1 (de) Verfahren zum Ausbringen von Dünger mit einem Schleuderdüngerstreuer.
DE58905890D1 (de) Verfahren zum Färben von Papier.
DE69202909T2 (de) Wässrige Harzzusammensetzung und Verfahren zur Beschichtung von Dosen.
DE29502925U1 (de) Malgerät zum Verzieren von Farbeiern

Legal Events

Date Code Title Description
8364 No opposition during term of opposition